New England Capital Financial Advisors’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $813 | Hold |
300
| – | – | ﹤0.01% | 370 |
|
|
2025
Q1 | $675 | Hold |
300
| – | – | ﹤0.01% | 346 |
|
|
2024
Q4 | $1.05K | Hold |
300
| – | – | ﹤0.01% | 353 |
|
|
2024
Q3 | $1.23K | Hold |
300
| – | – | ﹤0.01% | 338 |
|
|
2024
Q2 | $1.08K | Hold |
300
| – | – | ﹤0.01% | 339 |
|
|
2024
Q1 | $990 | Hold |
300
| – | – | ﹤0.01% | 338 |
|
|
2023
Q4 | $693 | Hold |
300
| – | – | ﹤0.01% | 356 |
|
|
2023
Q3 | $387 | Hold |
300
| – | – | ﹤0.01% | 366 |
|
|
2023
Q2 | $396 | Hold |
300
| – | – | ﹤0.01% | 362 |
|
|
2023
Q1 | $213 | Hold |
300
| – | – | ﹤0.01% | 416 |
|
|
2022
Q4 | $291 | Buy |
+300
| New | +$291 | ﹤0.01% | 408 |
|